Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Multiplex Biomarker Imaging Market Today And What Is Its Future Size?

In recent years, the industry of multiplex biomarker imaging has seen a blistering pace of expansion. The market size, which stood at a valuation of $0.49 billion in 2024, is anticipated to climb to $0.54 billion in 2025, posting a compound annual growth rate (CAGR) of 10.7%. This expansion was driven by factors such as a rise in cancer incidence, the necessity for accurate diagnostic devices, a surge in chronic diseases, growth in the elderly population and a trend towards individualized medicine.

The market size for multiplex biomarker imaging is projected to experience accelerated expansion in the coming years, reaching a valuation of $0.8 billion in 2029 with a 10.1% compound annual growth rate. The forecasted growth is primarily driven by a heightened focus on personalized medicine, escalating research and development activities, an augmentation in clinical trials, a demand for more efficient drug discovery via high throughput screening techniques and supportive regulatory structures and guidelines. Major predictive trends for this period include advancements in technology, novel imaging technologies, progression in digital pathology, software developments for data analysis and imaging, alongside the intertwining of AI and machine learning with imaging technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16127&type=smp

What External And Internal Drivers Are Influencing The Multiplex Biomarker Imaging Market?

The burgeoning incidence of long-term health issues is foreseen to spur the expansion of the multiplex biomarker imaging market. Chronic diseases are medical conditions that endure or resurface repeatedly, often caused by an intricate blend of factors, multiple risk elements, and extended latency periods. The surging incidence of chronic diseases can be traced back to various factors, such as the swift aging of the populace, enhanced detection and discovery, better illness treatment and management, along with changes in environmental risk factors and lifestyle. Multiplex biomarker imaging plays a crucial role in the management of chronic diseases by offering a comprehensive analysis and detailed information about disease progression and response to treatment. As an illustration, in January 2023, a report by the National Institutes of Health (NIH), a biomedical research institution based in the US, projected that the count of individuals aged 50 and above suffering from at least one chronic disease is expected to increase by 99.5%, shifting from 71.52 million in 2020 to an astounding 142.66 million in 2050. Hence, the escalating incidence of chronic diseases is propelling the expansion of the multiplex biomarker imaging market.

How Is The Multiplex Biomarker Imaging Market Categorized Across Applications And Types?

The multiplex biomarker imagingmarket covered in this report is segmented –

1) By Component Type: Instruments; Software; Services

2) By Imaging Techniques: Immuno Fluorescence (IF) Assay; Tissue Microarray (TMA) Assay; Immunohistochemistry (IHC) Assay; Fluorescent In The Situ Hybridization (FISH) Assay; Toponome Imaging System (TIS)

3) By Application: Drug Safety; Oncology Studies; Genetic Characterization Studies

4) By End User: Research Institutes Government And Private; Clinical Labs; Pharmaceutical And Biotechnology

Subsegments:

1) By Instruments: Imaging Systems (Microscopes, Scanners); Detection Devices (Sensors, Probes); Reagents And Kits

2) By Software: Image Analysis Software; Data Management Software; Visualization And Interpretation Software

3) By Services: Technical Support And Maintenance; Consultation And Training; Imaging And Analysis Services

How Are Industry Trends Steering The Expansion Of The Multiplex Biomarker Imaging Market?

Leading firms involved in the multiplex biomarker imaging market are prioritizing the provision of inventive slides like automated slide loaders to enhance imaging solutions and improve customer service. These automated slide loaders simplify sample management, decrease manual intervention, and increase output, a critical factor for substantial multiplex biomarker imaging experiments. For example, in April 2024, Standard BioTools Inc., a US-based analytical systems and instruments provider introduced a Hyperion XTi Imaging System equipped with a new high-throughput multiplexed whole slide to increase automation and versatility. The system features three modes for quick analysis, namely, preview, tissue, and cell modes. This allows researchers to quickly observe tissue variability and perform more detailed analysis. The inventive whole slide imaging technique uses imaging mass cytometry (IMC), providing up to tenfold greater throughput than cyclic immunofluorescent imaging. An included automated slide loader further boosts high-throughput imaging, decreases manual intervention, and allows standardization. These advancements were designed to hasten progress in spatial proteomics and give trustworthy insights into health and disease conditions.

Who Are The Global Leaders Steering The Multiplex Biomarker Imaging Market Forward?

Major companies operating in the multiplex biomarker imaging market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher corporation, Becton Dickinson and Company (BD), Carl Zeiss AG, Illumina Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc, Bruker Corporation, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Abcam Plc, Meso Scale Diagnostics LLC, Fluidigm Corporation, NanoString Technologies, Quanterix Corporation, Akoya Biosciences, Enzo Biochem Inc, Cisbio Bioassays, Flagship Biosciences, Aushon BioSystems Ltd, Ionpath Inc., Biosims Technologies

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report

What Are The Emerging Regional Trends Driving The Multiplex Biomarker Imaging Market?

North America was the largest region in the multiplex biomarker imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex biomarker imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16127&type=smp

Browse Through More Reports Similar to the Global Multiplex Biomarker Imaging Market 2025, By The Business Research Company

Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model